Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors door Katrina M. Lappin (9340394)

Onderwerpen:

Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors door Katrina M. Lappin (9340394)

Onderwerpen:

Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors door Katrina M. Lappin (9340394)

Onderwerpen:

Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors door Katrina M. Lappin (9340394)

Onderwerpen:

Supplementary Table S2 from Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment door Konjeti R. Sekhar (15400345)

Onderwerpen:

Supplementary Table S1 from Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment door Konjeti R. Sekhar (15400345)

Onderwerpen:

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects door Sami Belhadj (15052341)

Onderwerpen:

Supplementary Table S1 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers door Rongxin Zhang (15293341)

Onderwerpen:

Supplementary Table S2 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers door Rongxin Zhang (15293341)

Onderwerpen:

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer door Min Wei (16918572)

Onderwerpen:

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer door Min Wei (16918572)

Onderwerpen:

Table S15 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer door Aditi S. Khatpe (15293176)

Onderwerpen:

Table S4 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer door Aditi S. Khatpe (15293176)

Onderwerpen:

Table S3 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer door Aditi S. Khatpe (15293176)

Onderwerpen:

Table S10 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer door Aditi S. Khatpe (15293176)

Onderwerpen:

Table S9 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer door Aditi S. Khatpe (15293176)

Onderwerpen:

Table S14 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer door Aditi S. Khatpe (15293176)

Onderwerpen:

Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers door Timothy P. DiPeri (16384177)

Onderwerpen:

Table S1 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer door Aditi S. Khatpe (15293176)

Onderwerpen:

Table S2 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer door Aditi S. Khatpe (15293176)

Onderwerpen: